$49.93 USD (0.00% in 24 hours)
CRISPR Therapeutics AG is a clinical-stage biopharmaceutical pioneer focused on translating revolutionary.
As of 2026-11-01 00:19 UTC. The Crypto App market data.
CRISPR Therapeutics AG is a clinical-stage biopharmaceutical pioneer focused on translating revolutionary Nobel Prize-winning CRISPR-Cas9 gene-editing technology into curative medical therapies. The firm's advanced R&D pipeline targets severe hemoglobinopathies (such as sickle cell disease), immuno-oncology cell therapies (CAR-T), and regenerative medicine, with its asset valuation dictated by clinical…